Cited 0 time in
INCREASED SERUM LEVEL OF IL-36 RECEPTOR ANTAGONIST IS ASSOCIATED WITH ACTIVE DISEASE IN PATIENTS WITH ADULT-ONSET STILL’S DISEASE
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 유대현 | - |
| dc.date.accessioned | 2021-08-02T19:56:14Z | - |
| dc.date.available | 2021-08-02T19:56:14Z | - |
| dc.date.issued | 2018-06-09 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/28461 | - |
| dc.title | INCREASED SERUM LEVEL OF IL-36 RECEPTOR ANTAGONIST IS ASSOCIATED WITH ACTIVE DISEASE IN PATIENTS WITH ADULT-ONSET STILL’S DISEASE | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | EULAR 2018 | - |
| dc.citation.conferencePlace | Amsterdam, Netherland | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
